Facile Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Facile Therapeutics General Information

Description

Operator of a biotechnology company intended to develop therapeutic drugs for Clostridium difficile infection. The company is developing a potent anti-toxin drug that does not cause the death of healthy gut bacteria that normally makes the colon resistant to C diff reinfection, providing healthcare professionals with an alternative treatment to antibiotics without killing healthy gut bacteria.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2708 Wemberly Drive
  • Belmont, CA 94002
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2708 Wemberly Drive
  • Belmont, CA 94002
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Facile Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 08-Dec-2021 Completed Out of Business
4. Grant 01-Feb-2020 Completed Generating Revenue
3. Seed Round 18-Jul-2019 Completed Generating Revenue
2. Accelerator/Incubator $300K Completed Pre-Clinical Trials
1. Accelerator/Incubator 31-Mar-2018 $300K $300K Completed Pre-Clinical Trials
To view Facile Therapeutics’s complete valuation and funding history, request access »

Facile Therapeutics FAQs

  • When was Facile Therapeutics founded?

    Facile Therapeutics was founded in 2017.

  • Where is Facile Therapeutics headquartered?

    Facile Therapeutics is headquartered in Belmont, CA.

  • What industry is Facile Therapeutics in?

    Facile Therapeutics’s primary industry is Drug Discovery.

  • Is Facile Therapeutics a private or public company?

    Facile Therapeutics is a Private company.

  • What is Facile Therapeutics’s current revenue?

    The current revenue for Facile Therapeutics is .

  • How much funding has Facile Therapeutics raised over time?

    Facile Therapeutics has raised $300K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process